The "Dermatophytosis: Market View" report has been added to ResearchAndMarkets.com's offering.

This reports provides a data-driven overview of the current and future competitive landscape in dermatophytosis Therapeutics.

India is projected to have the highest number of diagnosed prevalent cases of dermatophytosis in both 2024 and 2029, contributing 32.28% and 32.98% of cases, respectively.

The dermatophytosis treatment market is largely saturated with generics, with antifungal agents comprising the majority of approved innovator drugs currently available. The pipeline for dermatophytosis remains limited, with no drug in the pre-registration stage, one drug in Phase III, and three drugs in Phase II.

Over the past decade, 210 clinical trials were initiated for dermatophytosis. The years with the most trials initiated in dermatophytosis were 2023 with 36 trials, followed by 2022 and 2019 with 23 and 22 trials, respectively. In the past two years, one strategic alliance involving companies developing dermatophytosis assets has been completed, nine mergers and acquisition deals have been completed, and eight merger and acquisitions have been announced.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the dermatophytosis Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the global dermatophytosis Therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories that present the maximum opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:

1 Preface

1.1 Contents

1.2 Report Scope

1.3 List of Tables and Figures

1.4 Abbreviations

2 Key Findings

3 Disease Landscape

3.1 Disease Overview

3.2 Epidemiology Overview

3.3 Treatment Overview

4 Marketed Drugs Assessment

4.1 Leading Marketed Drugs

4.2 Overview by Mechanism of Action

4.3 Overview by Molecule Type

4.4 Product Profiles and Sales Forecast

5 Pricing and Reimbursement Assessment

5.1 Annual Cost of Therapy

5.2 Time to Pricing and Reimbursement

6 Pipeline Drugs Assessment

6.1 Mid-to-late-stage Pipeline Drugs

6.2 Overview by Development Stage

6.3 Overview by Mechanism of Action

6.4 Overview by Molecule Type

6.5 Drug Specific Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA)

6.6 Therapy Area and Indication-specific PTSR and LoA

7 Clinical Trials Assessment

7.1 Historical Overview

7.2 Overview by Phase

7.3 Overview by Status

7.4 Overview by Phase for Ongoing and Planned Trials

7.5 Trials with Virtual Components

7.6 Overview of Trials by Geography

7.7 Single-Country and Multinational Trials by Region

7.8 Top 20 Sponsors with Breakdown by Phase

7.9 Top 20 Sponsors with Breakdown by Status

7.10 Overview by Endpoint Status

7.11 Overview by Race and Ethnicity

7.12 Enrollment Data

7.13 Top 20 countries for Trial Sites

7.14 Top 20 Sites Globally

7.15 Feasibility Analysis - Geographic Overview

7.16 Feasibility Analysis - Benchmark Models

8 Deals Landscape

8.1 Mergers, Acquisitions, and Strategic Alliances by Region

8.2 Recent Mergers, Acquisitions, and Strategic Alliances

9 Commercial Assessment

9.1 Key Market Players

10 Future Market Catalysts

11 Appendix

11.1 Methodology

11.2 Methodology - Sales Forecast

11.3 Methodology - Pricing and Reimbursement

11.4 Methodology - PTSR and LoA Analysis

For more information about this report visit https://www.researchandmarkets.com/r/9gutix

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251203504606/en/